Abstract
The study presents the case of a 78-year-old woman with recurrent pulmonary embolism, treated with 2 courses of thrombolysis. In this patient, due to heparin-induced thrombocytopenia, fondaparinux therapy was used.
MeSH terms
-
Aged
-
Anticoagulants / therapeutic use*
-
Female
-
Fondaparinux
-
Heparin / adverse effects*
-
Humans
-
Polysaccharides / therapeutic use
-
Pulmonary Embolism / chemically induced*
-
Pulmonary Embolism / drug therapy*
-
Recurrence
-
Thrombocytopenia / chemically induced*
-
Treatment Outcome
Substances
-
Anticoagulants
-
Polysaccharides
-
Heparin
-
Fondaparinux